Atopic dermatitis (AD) of the adult is a common skin disease. Its prevalence has greatly
increased during the past decades. AD is commonly associated with other atopic disorders …

Contrary to psoriasis, the treatment of moderate-tosevere AD remained challenging and
limited. Cyclosporine is the only systemic agent approved for the treatment of AD in many …

Atopic dermatitis (AD) is a chronic inflammatory skin disease presenting with recurrent
eczematous lesions and intense pruritus. It is common and affects both children and adults …

An update to the atopic dermatitis (AD) practice parameter was published in 2013 using an
established grading system for determining category of evidence and strength of …

Atopic dermatitis (AD) has a prevalence of 1%-3% in adults. Adult-onset AD has only been
defined recently, and lack of familiarity with this condition and confusion regarding the …

Atopic dermatitis is a Th2 disease, due to relapse of IL-4 and IL-13 by Th2 cells. Despite the
approval by FDA of dupilumab, the first monoclonal antibody for the severe forms, traditional …

Atopic dermatitis (AD) is a chronic or chronically relapsing inflammatory skin disease which
results from a complex, multifaceted interaction between environmental factors in genetically …

Introduction: Atopic dermatitis is the most common chronic inflammatory skin disease with
high prevalence rates in adults and even higher among children. For the numerous patients …

Introduction: Dupilumab is a new treatment option for patients with moderate-to-severe
atopic dermatitis. It blocks IL-4/IL13-signaling and thereby inhibits receptor signaling …

Atopic dermatitis (AD) is a chronic, pruritic, inflammatory skin disease which predominantly
affects children usually clearing up during or after childhood. However, AD may persist with …